Nephrological perspectives on the underutilization of SGLT2is in heart failure and chronic kidney disease

Nephrological perspectives on the underutilization of SGLT2is in heart failure and chronic kidney disease

Saved in:

Bibliographic Details
Main Authors:	Özant Helvacı, Ömer Faruk Akçay, Emre Yaşar, Ülver Derici, Galip Güz
Format:	Article
Language:	English
Published:	Wiley 2025-04-01
Series:	ESC Heart Failure
Online Access:	https://doi.org/10.1002/ehf2.15230
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Response to the Nephrological perspectives on the underutilization of SGLT2i in heart failure and chronic kidney disease
by: Umut Kocabas
Published: (2025-04-01)

Challenging the Restrictive Approach: Reconsidering Sodium-Glucose Transport Protein 2 Inhibitor Use in CKD
by: Ozant Helvaci, et al.
Published: (2024-06-01)

Impact of SGLT-2 Inhibitors on Biomarkers of Heart Failure
by: Dana Darwish, et al.
Published: (2025-06-01)

Concerns Regarding Renal Function Claims in Low‐Dose Spironolactone Study
by: Özant Helvacı, et al.
Published: (2025-07-01)

The missing piece in post-transplant bone health: tertiary hyperparathyroidism management
by: Burçak Cavnar Helvacı, et al.
Published: (2025-07-01)

SGLT2 Inhibitors in Patients with Chronic Kidney Disease and Heart Disease: A Literature Review
by: Abhishek Kansara, et al.
Published: (2022-09-01)

Concurrent extramedullary hematopoiesis and AA amyloidosis in the kidney
by: Özant Helvaci, et al.
Published: (2025-03-01)

Underutilization of palliative care in advanced COPD and heart failure: associations, disparities, and the role of specialists
by: Lior Zornitzki, et al.
Published: (2025-08-01)

Dual-faced guardians: SGLT2 inhibitors’ kidney protection and health challenges: a position statement by Kasralainy nephrology group (KANG)
by: Amin Roshdy Soliman, et al.
Published: (2025-06-01)

SGLT-2 inhibitors in the management of acute decompensated heart failure
by: Anastasia E. Poskakalova, et al.
Published: (2024-11-01)

Effect of SGLT2 inhibitors on the course of chronic heart failure in patients with type 2 diabetes mellitus
by: A. N. Payudis, et al.
Published: (2022-10-01)

Cardiovascular and nephrological risk in patients with chronic kidney disease in ambulatory care.
by: O. Kuryata, et al.
Published: (2019-11-01)

PROFILE OF CHILDREN AND ADOLESCENTS WITH CHRONIC RENAL FAILURE FOLLOWED UP AT NEPHROLOGY UNITS
by: Juliana Oliveira Freitas Miranda, et al.
Published: (2013-04-01)

PROFILE OF CHILDREN AND ADOLESCENTS WITH CHRONIC RENAL FAILURE FOLLOWED UP AT NEPHROLOGY UNITS
by: Juliana Oliveira Freitas Miranda, et al.
Published: (2013-04-01)

PROFILE OF CHILDREN AND ADOLESCENTS WITH CHRONIC RENAL FAILURE FOLLOWED UP AT NEPHROLOGY UNITS
by: Juliana Oliveira Freitas Miranda, et al.
Published: (2013-04-01)

PROFILE OF CHILDREN AND ADOLESCENTS WITH CHRONIC RENAL FAILURE FOLLOWED UP AT NEPHROLOGY UNITS
by: Juliana Oliveira Freitas Miranda, et al.
Published: (2013-04-01)

Ultrasonography of vascular access in the hands of nephrology and nephrological nursing professionals in advanced chronic kidney disease units: A tool to improve the quality of care
by: Florentina Rosique, et al.
Published: (2024-11-01)

Effects of SGLT2 inhibitor dapagliflozin in patients with heart failure with reduced ejection fraction
by: N. R. Khasanov
Published: (2020-09-01)

Risk factors associated with SGLT2 inhibitor discontinuation in diabetic patients with heart failure.
by: Minkwan Kim, et al.
Published: (2024-01-01)

Risk of Kidney Failure and Mortality in Patients Under Nephrology Care in NonHigh-Income Settings
by: Murilo Guedes, et al.
Published: (2024-02-01)

Primary Care Physicians’ Perspective on SGLT2 Inhibitors for Chronic Kidney Disease
by: Sky Wei Chee Koh, FCFP, et al.
Published: (2025-06-01)

Generating kidney organoids based on developmental nephrology
by: Yutaro Ibi, et al.
Published: (2024-12-01)

KIDNEY DYSFUNCTION EVALUATION IN CHRONIC HEART FAILURE PATIENTS
by: U. K. Kamilova, et al.
Published: (2014-04-01)

Management of Heart Failure in Patients with Chronic Kidney Disease
by: David K Ryan, et al.
Published: (2022-07-01)

Long-term surrogate cardiovascular outcomes of SGLT2 inhibitor empagliflozin in chronic heart failure: a systematic review and meta-analysis
by: Qingkai Yan, et al.
Published: (2024-11-01)

Reversibility of chronic heart failure symptoms in chronic kidney disease patients
by: V. V. Belov, et al.
Published: (2007-02-01)

Chronic heart failure risk factors in patients with chronic kidney pathology
by: O. E. Ilyicheva
Published: (2008-02-01)

The Role of SGLT2-Inhibitors Across All Stages of Heart Failure and Mechanisms of Early Clinical Benefit: From Prevention to Advanced Heart Failure
by: Simone Pasquale Crispino, et al.
Published: (2025-03-01)

Sequels of COVID-19 in nephrology. Chronic kidney patients are more prone to hemodialysis need and mortality
by: Erjola Bolleku, et al.
Published: (2024-12-01)

Availability and prioritisation of COVID-19 vaccines among patients with advanced chronic kidney disease and kidney failure during the height of the pandemic: a global survey by the International Society of Nephrology
by: David W Johnson, et al.
Published: (2022-12-01)

Advancing Nephrology Education with POCUS: Key Insights From the American Society of Nephrology Kidney Week 2024 Precourse
by: Abhilash Koratala, et al.
Published: (2025-05-01)

The involvement of kidneys in chronic heart failure patients with liver steatosis
by: O. M. Drapkina, et al.
Published: (2016-02-01)

Gaps in Modern Heart Failure and Chronic Kidney Disease Research
by: Simran Singh Parmar, et al.
Published: (2023-08-01)

SGLT2i reduce arrhythmic events in heart failure patients with cardiac implantable electronic devices
by: Marco Valerio Mariani, et al.
Published: (2025-06-01)

Risk Behaviors in Teens with Chronic Kidney Disease: A Study from the Midwest Pediatric Nephrology Consortium
by: Nianzhou Xiao, et al.
Published: (2019-01-01)

Inflammation-based scores predict chronic kidney disease progression in patients with chronic kidney disease and chronic heart failure
by: Lu Cai, et al.
Published: (2024-12-01)

Predictors of failure to transition from pediatric to adult nephrology care
by: Laura Nishi, et al.
Published: (2025-07-01)

Advances in the mechanism of action of SGLT2 inhibitors on the kidney
by: JI Ying, et al.
Published: (2020-01-01)

Kidney involvement in monoclonal gammopathies: multidisciplinary approach in oncohematology and nephrology
by: A. V. Smirnov, et al.
Published: (2020-07-01)

SGLT2 inhibitor with and without ALDosterone AntagonIst for heart failure with preserved ejection fraction: Design paper
by: João Pedro Ferreira, et al.
Published: (2025-08-01)